2012

Articles

CHIEF MEDICAL EDITOR’S PAGE

THE LITERATURE

CHALLENGING CASES

SURGICAL PEARLS

COVER STORIES:
ADVANCES IN GLAUCOMA LASER THERAPY

THERAPEUTICS UPDATE

INSIDE EYTUBE.NET

View All News >
News
Glaucoma Candidate BOL‑303259‑X Meets Primary Endpoint in Phase 2b Study

A phase 2b study of BOL-303259-X met its primary efficacy endpoint and showed positive results on a number of secondary endpoints, according to Bausch + Lomb and NicOx SA. BOL-303259-X (previously NCX 116) was licensed by NicO... more >

News
Glaucoma Research Foundation Emphasizes Importance of Collaborative Research

The Glaucoma Research Foundation (GRF) announced that it will double its Catalyst for a Cure (CFC) research consortium to eight research scientists from prestigious universities across the United States. The Foundation also re... more >

News
Mobius Therapeutics Receives Final FDA Approval for Mitosol

The drug delivery platform Mitosol (Mobius Therapeutics, LLC) received approval from the FDA for use in glaucoma surgery, according to a company news release. Mitosol reportedly delivers a precise dose of its active ingredi... more >

News
Working Group Calls Preservative Toxicity a Disease

PThe Working Group on Preservative Toxicity, an advisory panel of glaucoma experts, was recently convened to examine the issue of preservatives in glaucoma medications from an evidence-based perspective. The Working Group, whi... more >

TOP 5 ARTICLES FROM APRIL 2012